17.40
2.79%
-0.50
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
10.79%
81.88
|
73.90 | 67.27 | 60.12 | 56.91 |
Cost Of Revenue |
0.12%
42.77
|
42.82 | 42.62 | 43.43 | 40.40 |
Gross Profit |
25.80%
39.11
|
31.09 | 24.65 | 16.69 | 16.51 |
Operating Expenses
|
2.57%
17.29
|
16.85 | 15.97 | 17.16 | 17.33 |
Interest Income/Expense |
39.35%
3.769
|
6.2149 | 6.3976 | 6.2991 | 6.1155 |
Benefits Costs and Expenses |
63.47
|
- | - | - | - |
Costs And Expenses |
6.37%
63.47
|
59.67 | 58.59 | 60.60 | 57.73 |
Depreciation and Amortization |
0.24%
2.114
|
2.109 | 2.0925 | 2.0976 | 2.033 |
Operating Income/Loss |
53.31%
21.82
|
14.23 | 8.6852 | -0.4731 | -0.8133 |
Nonoperating Income/Loss |
89.27%
-3.42
|
-31.88 | -6.1201 | -5.8976 | -5.9755 |
Income/Loss From Continuing Operations Before Tax |
75.10%
18.40
|
73.90 | 67.27 | -6.3707 | -6.7888 |
Income Tax Expense/Benefit |
0.595
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
200.92%
17.81
|
-17.64 | 2.5651 | -6.3707 | -6.7888 |
Net Income/Loss
|
200.92%
17.81
|
-17.64 | 2.5651 | -6.3707 | -6.7888 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
34,010%
228.87
|
0.671 | 225.28 | 222.68 | 221.92 |
Diluted Average Shares |
35,134%
236.41
|
0.671 | 233.76 | 222.68 | 221.92 |
Basic Earnings Per Share |
200.00%
0.08
|
-0.08 | 0.01 | -0.03 | -0.03 |
Diluted Earnings Per Share |
200.00%
0.08
|
-0.08 | 0.01 | -0.03 | -0.03 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):